• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 437992 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414839129 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414839129 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Analyst Rating In Review: Endo Pharmaceuticals Bid Up 8.6% Since Downgraded 7 Days Ago (ENDP)

Published on Thu, 02/07/2013 - 10:09
By Robert Cotter

A week ago, Oppenheimer downgraded Endo Pharmaceuticals from Outperform to Perform. The stock closed at $30.66, which is 8.6% higher than the price one week ago ($28.23).

In the past 52 weeks, shares of Endo Pharmaceuticals have traded between a low of $25.00 and a high of $44.53 and are now at $30.40, which is 22% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.2% while the 50-day MA has advanced 0.7%.

There is potential upside of 9.6% for shares of Endo Pharmaceuticals based on a current price of $30.40 and an average consensus analyst price target of $33.31. The stock should find initial support at its 200-day moving average (MA) of $30.27 and further support at its 50-day MA of $27.56.

Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company with products that provide pain management. The Company researches, develops, produces, and markets both branded and generic pharmaceuticals. Endo's products include Percocet, Percodan, and Lidoderm.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Zimmer Looks to Continue to Trade Above ...

Shares of Zimmer (NYSE:ZMH) traded today at $111.21, breaking its 52-week high. This n ...

Shares of Yahoo! Rise to a New 52-Week H...

Yahoo! (NASDAQ:YHOO) traded at a new 52-week high today of $46.52. So far today approx ...

Shares of Aqua America Rise to a New 52-...

Shares of Aqua America (NYSE:WTR) traded at a new 52-week high today of $26.42. This n ...

West Pharmaceutical Services: 52-Week Hi...

Shares of West Pharmaceutical Services (NYSE:WST) traded today at $51.63, breaking its ...

Recent 52-Week High Exceeded in Shares o...

Shares of WesBanco (NASDAQ:WSBC) traded at a new 52-week high today of $34.94. This ne ...

Recent 52-Week High Exceeded in Shares o...

Weingarten Realty Investors (NYSE:WRI) traded at a new 52-week high today of $36.02. S ...

Shares of WR Berkley Rise to a New 52-We...

WR Berkley (NYSE:WRB) traded today at a new 52-week high of $51.63. This new high was ...

VCA Antech: 52-Week High Recently Eclips...

Shares of VCA Antech (NASDAQ:WOOF) traded at a new 52-week high today of $45.94. So fa ...